
Hepa-B For Adult20 mcg/ml
Incepta Pharmaceuticals Ltd.
Hepatitis B Vaccine [rDNA] is indicated for active immunization against infection caused by all known subtypes of the hepatitis B virus (HBV).
Hepatitis B Vaccine [rDNA] is indicated for active immunization against infection caused by all known subtypes of the hepatitis B virus (HBV). It is used as follows:
| Population | Schedule | Typical Dose |
|---|---|---|
| Infants (routine schedule) | 3 doses at 0, 1, and 6 months (first dose at birth) | Pediatric formulation dose per product labeling |
| Infants born to HBsAg-positive mothers | Vaccine dose 1 plus HBIG within 12 hours of birth, then doses at 1 and 6 months | Pediatric formulation dose plus HBIG |
| Children/adolescents not previously vaccinated | 3-dose catch-up series at 0, 1, and 6 months | Pediatric or adult formulation per age/product |
| Adults | 3 doses at 0, 1, and 6 months | Adult formulation dose per product labeling |
| Adult hemodialysis/immunocompromised patients | Often a modified higher-dose schedule (e.g., 4 doses) per specific product labeling | Higher-dose formulation where available |
An accelerated schedule (e.g., 0, 1, and 2 months with a booster at 12 months) may be used for travelers needing rapid protection, per physician guidance. Exact dose volume and antigen content vary by manufacturer/product strength; always follow the specific product's prescribing information and the national immunization schedule.
Most adverse effects of Hepatitis B Vaccine [rDNA] are mild and self-limited.
Hepatitis B Vaccine [rDNA] is contraindicated in individuals with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.